Sage Journals: Discover world-class research

Retricted access

Research article

First published 2012-6

Deficiencies in generic product dossiers as submitted to the WHO Prequalification of Medicines Programme

Wondiyfraw Z Worku, John Gordon, Matthias MS Stahl [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2013-11

Statistics,Quality Review Issues,and Beyond for Generic Drug Applications in Taiwan

Lin-Chau Chang, Churn-Shiouh Gau

Therapeutic Innovation & Regulatory Science

Retricted access

Other

First published 2001-4

Main Deficiencies concerning the European Marketing Authorization: Part II

Yvonne Legras

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2010-1

Assessment Methodology for Performing Regulatory Due Diligence Based on a Quantitative Approach

Andrey Mladenov, Yuliana Maslarova, Eleonora Petkova [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Other

First published 2001-1

Preclinical Considerations for Regulatory Submissions

Paul Baldrick

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2016-3

Too Limited,Too Late: Evaluating the Czech Republic's Performance as a Small-State Lobbyist in EU External Policy

Tomáš Weiss

New Perspectives

Retricted access

Research article

First published 2025-9

WHO prequalification of medicines in low- and middle-income countries: Situational analysis of Nepali manufacturers and recommendations

Achyut Bikram Thapa, Rajani Shakya, Robhash Kusam Subedi [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Search results

Deficiencies in generic product dossiers as submitted to the WHO Prequalification of Medicines Programme

Statistics,Quality Review Issues,and Beyond for Generic Drug Applications in Taiwan

Main Deficiencies concerning the European Marketing Authorization: Part II

Assessment Methodology for Performing Regulatory Due Diligence Based on a Quantitative Approach

Preclinical Considerations for Regulatory Submissions

Too Limited,Too Late: Evaluating the Czech Republic's Performance as a Small-State Lobbyist in EU External Policy

WHO prequalification of medicines in low- and middle-income countries: Situational analysis of Nepali manufacturers and recommendations